mercredi 6 avril 2016

Onco Actu du 6 avril 2016

1. Biologie

JAX Researchers Reveal Genomic Culprit, Treatment Strategy for Some Deadly Cancers [JAX]

3. Prévention

Six ways to reduce your risk of bowel cancer [Cancer Research UK]

4.12 Biopsies liquides

Merck receive CE Mark approval for new liquid biopsy test for colorectal cancer [Pharmafile]

New Liquid Biopsy RAS Testing for Metastatic Colorectal Cancer Patients now Available for Clinical Practices [sysmex inostics]

5.2 Pharma

What new GSK patent policy means for the developing world [Nature News & Comment]

5.2.1 Pharma - Partenariats

MedImmune, Regeneron Launch Cancer Collaboration [GEN]

Old guard meets new as Pfizer and Merck start PDL1-TKI combo trial for kidney cancer [FierceBiotech]

5.2.2 Pharma - Fusions & Acquisitions

Pfizer to call off $160 billion merger with Allergan [Pharmafile]

5.4 Traitements - Economie

Cancer drug prices skyrocketing on high costs of developing 'molecular targeted drugs' [The Mainichi]

Making the Price Right: Ideas To Change Drug Costs Gain Momentum [Xconomy]

6. Lutte contre les cancers

Choir singing may boost immunity in people affected by cancer [NHS Choices]

Putting patients first to ease the effects of complex illnesses [NICE]

6.4 Médico-éco

Patients Miss Out On Savings When Doctors Fail To Talk About Costs [NPR]

6.6 Publications

ORCID: what, why, how? [BioMed Central blog]

Cancer researcher earns 9th retraction, for image duplication [Retraction Watch]

Amid Public Feuds, A Venerated Medical Journal Finds Itself Under Attack [Pro Publica]

6.7.2 Applis

Why every clinical trial should have an app for participants [STAT]